BirchBioMed Inc. (BRBM)

BirchBioMed will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BirchBioMed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-4.24	-4.55	-0.89
Share-Based Compensation	-	0.61	-
Other Operating Activities	2.11	1.74	0.1
Operating Cash Flow	-2.13	-2.2	-0.79
Operating Cash Flow Growth	-	-	-

Financing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	0.24	-
Debt Issued / Paid	-	4.57	-
Financing Cash Flow	5.11	4.81	-

Net Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	2.99	2.61	-0.79

Free Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-2.13	-2.2	-0.79
Free Cash Flow Growth	-	-	-